Predicting the need for surgery in obstructive Crohn's disease: How hot is PET/CT?

Inflammatory Bowel Diseases

Volumn 16, Issue 12, 2010, Pages 2182-2183

  Sahni, V Anik ^a   Shyn, Paul B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DIAGNOSTIC ACCURACY; FIBROSIS; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTESTINE OBSTRUCTION; INTESTINE RESECTION; INTESTINE STENOSIS; MEDICAL DECISION MAKING; MUSCLE HYPERTROPHY; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 78649549656     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21335     Document Type: Note

References (14)

1. Bicik I, Bauerfeind P,. Inflammatory bowel disease activity measured by positron-emission tomography. Lancet. 1997; 350: 262.
2. Skehan SJ, Issenman R, Mernagh J, et al. 18F-fluorodexyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. Lancet. 1999; 354: 836-837.
3. Loffler M, Weckesser M, Franzius C, et al. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann N Y Acad Sci. 2006; 1072: 379-385.
4. Lemberg DA, Issenman RM, Cawdron R, et al. Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 733-738.
5. Neurath MF, Vehling D, Schunk K, et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am J Gastroenterol. 2002; 97: 1978-1985.
6. Louis E, Ancion G, Colard A, et al. Noninvasive assessment of Crohn's disease intestinal lesions with 18F-FDG PET/CT. J Nucl Med. 2007; 48: 1053-1059.
7. Spier BJ, Perlman SB, Jaskowiak CJ, et al. PET/CT in the evaluation of inflammatory bowel diseases: studies in patients before and after treatment. Mol Imaging Biol. 2010; 12: 85-88.
8. Jacene HA, Ginsburg P, Kwon J, et al. Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT. J Nucl Med. 2009; 1751-1759.
9. Graham MF,. Pathogenesis of intestinal structure in Crohn's disease - an update. Inflamm Bowel Dis. 1995; 1: 220-227.
10. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001; 49: 777-782.
11. Burke JP, Mulsow JJ, O'Keane C, et al. Fibrogenesis in Crohn's disease. Am J Gasterenterol. 2007; 102: 439-448.
12. Spinelli A, Correale C, Szabo H, et al. Intestinal fibrosis in Crohn's disease: medical treatment or surgery? Curr Drug Targets. 2010; 11: 242-248.
13. Stahl A, Weber WA, Avril N, et al. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin. 2000; 39: 241-245.
14. Ahmadi A, Li Q, Muller K, et al. Diagnostic value of noninvasive combined fluorine-18 labeled fluro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease. Inflamm Bowel Dis. 2009 [Epub ahead of print].